Experts have asserted that “the consumer is ready” for biotics delivering targeted benefits as opposed to general microbiome support, amid a rising demand for psychobiotics and an increasing awareness of the gut-brain axis.
A blend of four probiotic strains may lead to “widespread improvements” in measures of mood, anxiety, and depression in healthy young men and women, says a new study using Probiotical’s multi-strain probiotic, Bifizen.
In a report issued this week, Novozymes OneHealth shared current consumer perspectives and trends to help dietary supplement companies meet evolving needs in a fast-growing mental wellness market.
As consumers get more comfortable with probiotics for gut health, “probiotics plus” is emerging as a key motif. The idea of probiotics for mood support, or psychobiotics, is picking up steam as growing research shows the digestive aids hold promise for...
Novozymes OneHealth, supplier of probiotics, enzymes, and bioactive ingredients, exhibited its ‘ProbioBrain’ psychobiotic containing the targeted Bifidobacterium Longum 1714 strain, at Vitafoods last week.
Entrepreneurs developing next-gen CRISPR-engineered microbiome therapeutics for cognitive health will present their business to gut health experts at NI's Probiota event next month (Feb 6-8).
Braincare startup Heights has added a second product, a bundle of tried-and-true probiotic strains to support mood, stress response, immunity and gut health all at once.
Research continues to build the nutritional toolbox that can be accessed to help improve psychiatric outcomes by boosting the production of various neurotransmitters, a new review asserts.
Daily supplementation with Bifidobacterium longum BB68S may improve measures of cognitive function, including memory and attention, in older people, says a new study.
A probiotic that promotes benefits to mental health is the finding of a recent study that implicates the gut-brain axis in the reduction of stress, anxiety, and insomnia amongst test subjects.
The gut-brain axis is a hot topic amongst scientists, doctors, and dietary supplement businesses today, but this was not the case just five years ago, where the idea of using probiotics to address mental and cognitive health issues was met with much scepticism.
A specific combination of two probiotic strains may boost levels of BDNF (brain-derived neurotrophic factor) and improve depressive symptoms in people with depressions, says a new study.
European health firm Beopanax are the partners of choice to distribute a new psychobiotic product to new regions with claims it can induce a range of mental health benefits.
Taiwan's Bened Biomedical is expanding its psychobiotic business from APAC to Europe, with a new proprietary probiotic strain, as well as recent research on its established PS128 product, driving the firm's continued growth.
